Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03664739 · ClinicalTrials.gov registry record · Phase 3
Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
A Phase 3 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 3
- Development phase
- 608
- Enrollment target
NCT03664739 is a Phase 3 study that has completed, run by Bausch Health Americas. The registered enrollment target is 608 participants.
The verdict
NCT03664739, a Phase 3 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 608 participants
- Enrollment target
Study Summary
study designed to assess the safety, tolerability, and efficacy of IDP-120 Gel and IDP-120 Vehicle Gel
Interventions
- DRUG IDP-120 Gel
- DRUG IDp-120 Vehicle Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 608 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2020-03-23 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03664739
The ClinicalTrials.gov registry entry for NCT03664739 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 608 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IDP-120 Gel is the first listed.
NCT03664739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03664739 about?
NCT03664739 is a clinical study titled "Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris". study designed to assess the safety, tolerability, and efficacy of IDP-120 Gel and IDP-120 Vehicle Gel
What is the current status of trial NCT03664739?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 608 participants. The study started on 2018-12-05. Estimated completion is 2020-03-23.
What interventions are being tested in trial NCT03664739?
The interventions under investigation include: IDP-120 Gel (DRUG), IDp-120 Vehicle Gel (DRUG).
Who is sponsoring clinical trial NCT03664739?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.